β-Amyloid peptide (16-20)

This peptide, comprising the KLVFF sequence from amyloid-β, is a well-characterized inhibitor of Aβ fibrillogenesis. The addition of solubility-enhancing RG-/-GR-NH2 termini facilitates its use in both in vitro aggregation assays and cellular models of amyloid toxicity for Alzheimer's disease research.